SEC Form 4 · accession 0001610950-17-000047
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher L Gaenzle
Officer — CAO, GC & Sec
Period of report
Sep 1, 2017
Accepted (ET)
Sep 5, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 1, 2017 | M | 4,733 | $10.57 | A | 69,557 | D | |
| Class A Common StockF2 | Sep 1, 2017 | S | 4,733 | $58.352 | D | 64,824 | D | |
| Class A Common Stock | Sep 1, 2017 | M | 14,200 | $10.06 | A | 79,024 | D | |
| Class A Common StockF3 | Sep 1, 2017 | S | 9,467 | $58.467 | D | 69,557 | D | |
| Class A Common StockF4 | Sep 1, 2017 | S | 4,733 | $58.674 | D | 64,824 | D | |
| Class A Common Stock | Sep 1, 2017 | M | 23,668 | $16.06 | A | 88,492 | D | |
| Class A Common StockF5 | Sep 1, 2017 | S | 10,198 | $59.099 | D | 78,294 | D | |
| Class A Common StockF6 | Sep 1, 2017 | S | 1,636 | $59.602 | D | 76,658 | D | |
| Class A Common StockF7 | Sep 1, 2017 | S | 11,834 | $58.455 | D | 64,824 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F8 | $10.57 | Sep 1, 2017 | M | 4,733 | D | — | Apr 2, 2022 | Class A Common Stock | 4,733 | 0 | D |
| Stock Option (Right to Buy Class A Common Stock)F8 | $10.06 | Sep 1, 2017 | M | 14,200 | D | — | Aug 18, 2023 | Class A Common Stock | 14,200 | 0 | D |
| Stock Option (Right to Buy Class A Common Stock)F8 | $16.06 | Sep 1, 2017 | M | 23,668 | D | — | Jun 30, 2024 | Class A Common Stock | 23,668 | 0 | D |
Explanation of responses
- F1The transaction reported on this form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2017.
- F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $58.25 to $58.50, inclusive. The reporting person will provide to INC Research Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $58.20 to $58.60, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $58.55 to $58.80, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $58.60 to $59.58, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F6The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $59.60 to $59.65, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F7The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $58.10 to $58.70, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F8The shares subject to this option vested on August 1, 2017.